vs
Kosmos Energy Ltd.（KOS）与Prestige Consumer Healthcare Inc.（PBH）财务数据对比。点击上方公司名可切换其他公司
Kosmos Energy Ltd.的季度营收约是Prestige Consumer Healthcare Inc.的1.0倍（$294.6M vs $283.4M），Prestige Consumer Healthcare Inc.同比增速更快（-2.4% vs -25.9%），过去两年Prestige Consumer Healthcare Inc.的营收复合增速更高（1.2% vs -16.5%）
科斯莫斯能源是一家美国上游石油企业，总部位于得克萨斯州达拉斯。公司目前在加纳、赤道几内亚近海以及墨西哥湾开展油气生产与开发业务，在毛里塔尼亚、塞内加尔近海拥有开发项目，还在纳米比亚、圣多美和普林西比、苏里南近海持有勘探许可。
Prestige Consumer Healthcare Inc.是一家美国企业，主营非处方健康护理产品及家用清洁产品的营销与分销业务。该公司于1996年由Medtech Products、Prestige Brands International及Spic and Span三家公司合并成立，总部位于纽约州塔里敦，在弗吉尼亚州林奇堡设有生产工厂。
KOS vs PBH — 直观对比
营收规模更大
KOS
是对方的1.0倍
$283.4M
营收增速更快
PBH
高出23.5%
-25.9%
两年增速更快
PBH
近两年复合增速
-16.5%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $294.6M | $283.4M |
| 净利润 | — | $46.7M |
| 毛利率 | — | 55.5% |
| 营业利润率 | -125.7% | 29.1% |
| 净利率 | — | 16.5% |
| 营收同比 | -25.9% | -2.4% |
| 净利润同比 | — | -23.5% |
| 每股收益（稀释后） | $-0.80 | $0.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KOSPBH
| Q4 25 | $294.6M | $283.4M | ||
| Q3 25 | $311.0M | $274.1M | ||
| Q2 25 | $392.6M | $249.5M | ||
| Q1 25 | $290.1M | $296.5M | ||
| Q4 24 | $397.6M | $290.3M | ||
| Q3 24 | $407.8M | $283.8M | ||
| Q2 24 | $447.8M | $267.1M | ||
| Q1 24 | $422.3M | $277.0M |
净利润KOSPBH
| Q4 25 | — | $46.7M | ||
| Q3 25 | $-124.3M | $42.2M | ||
| Q2 25 | $-87.7M | $47.5M | ||
| Q1 25 | $-110.6M | $50.1M | ||
| Q4 24 | — | $61.0M | ||
| Q3 24 | $45.0M | $54.4M | ||
| Q2 24 | $59.8M | $49.1M | ||
| Q1 24 | $91.7M | $49.5M |
毛利率KOSPBH
| Q4 25 | — | 55.5% | ||
| Q3 25 | — | 55.3% | ||
| Q2 25 | — | 56.2% | ||
| Q1 25 | — | 57.3% | ||
| Q4 24 | — | 55.5% | ||
| Q3 24 | — | 55.5% | ||
| Q2 24 | — | 54.7% | ||
| Q1 24 | — | 54.8% |
营业利润率KOSPBH
| Q4 25 | -125.7% | 29.1% | ||
| Q3 25 | -34.2% | 29.1% | ||
| Q2 25 | -16.2% | 28.8% | ||
| Q1 25 | -32.4% | 29.8% | ||
| Q4 24 | -8.5% | 31.7% | ||
| Q3 24 | 26.1% | 29.7% | ||
| Q2 24 | 30.2% | 27.0% | ||
| Q1 24 | 33.6% | 29.7% |
净利率KOSPBH
| Q4 25 | — | 16.5% | ||
| Q3 25 | -40.0% | 15.4% | ||
| Q2 25 | -22.3% | 19.0% | ||
| Q1 25 | -38.1% | 16.9% | ||
| Q4 24 | — | 21.0% | ||
| Q3 24 | 11.0% | 19.2% | ||
| Q2 24 | 13.3% | 18.4% | ||
| Q1 24 | 21.7% | 17.9% |
每股收益（稀释后）KOSPBH
| Q4 25 | $-0.80 | $0.97 | ||
| Q3 25 | $-0.26 | $0.86 | ||
| Q2 25 | $-0.18 | $0.95 | ||
| Q1 25 | $-0.23 | $1.00 | ||
| Q4 24 | $0.00 | $1.22 | ||
| Q3 24 | $0.09 | $1.09 | ||
| Q2 24 | $0.12 | $0.98 | ||
| Q1 24 | $0.19 | $0.98 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $91.5M | $62.4M |
| 总债务越低越好 | $3.1B | $1.0B |
| 股东权益账面价值 | $528.6M | $1.8B |
| 总资产 | $4.7B | $3.5B |
| 负债/权益比越低杠杆越低 | 5.78× | 0.56× |
8季度趋势，按日历期对齐
现金及短期投资KOSPBH
| Q4 25 | $91.5M | $62.4M | ||
| Q3 25 | $64.0M | $119.1M | ||
| Q2 25 | $51.7M | $139.5M | ||
| Q1 25 | $49.8M | $97.9M | ||
| Q4 24 | $85.0M | $50.9M | ||
| Q3 24 | $51.6M | $51.5M | ||
| Q2 24 | $173.8M | $34.3M | ||
| Q1 24 | $254.3M | $46.5M |
总债务KOSPBH
| Q4 25 | $3.1B | $1.0B | ||
| Q3 25 | $3.0B | $993.1M | ||
| Q2 25 | $2.9B | $992.7M | ||
| Q1 25 | — | $992.4M | ||
| Q4 24 | $2.7B | $992.0M | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $1.1B |
股东权益KOSPBH
| Q4 25 | $528.6M | $1.8B | ||
| Q3 25 | $898.8M | $1.8B | ||
| Q2 25 | $1.0B | $1.9B | ||
| Q1 25 | $1.1B | $1.8B | ||
| Q4 24 | $1.2B | $1.8B | ||
| Q3 24 | $1.2B | $1.7B | ||
| Q2 24 | $1.1B | $1.7B | ||
| Q1 24 | $1.1B | $1.7B |
总资产KOSPBH
| Q4 25 | $4.7B | $3.5B | ||
| Q3 25 | $5.1B | $3.4B | ||
| Q2 25 | $5.2B | $3.4B | ||
| Q1 25 | $5.3B | $3.4B | ||
| Q4 24 | $5.3B | $3.3B | ||
| Q3 24 | $5.5B | $3.3B | ||
| Q2 24 | $5.4B | $3.3B | ||
| Q1 24 | $5.4B | $3.3B |
负债/权益比KOSPBH
| Q4 25 | 5.78× | 0.56× | ||
| Q3 25 | 3.31× | 0.54× | ||
| Q2 25 | 2.80× | 0.54× | ||
| Q1 25 | — | 0.54× | ||
| Q4 24 | 2.29× | 0.55× | ||
| Q3 24 | — | 0.61× | ||
| Q2 24 | — | 0.65× | ||
| Q1 24 | — | 0.68× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $35.3M | $78.3M |
| 自由现金流经营现金流 - 资本支出 | — | $75.3M |
| 自由现金流率自由现金流/营收 | — | 26.6% |
| 资本支出强度资本支出/营收 | — | 1.1% |
| 现金转化率经营现金流/净利润 | — | 1.68× |
| 过去12个月自由现金流最近4个季度 | — | $267.2M |
8季度趋势，按日历期对齐
经营现金流KOSPBH
| Q4 25 | $35.3M | $78.3M | ||
| Q3 25 | $-27.6M | $57.5M | ||
| Q2 25 | $127.2M | $79.0M | ||
| Q1 25 | $-888.0K | $61.8M | ||
| Q4 24 | $175.7M | $65.1M | ||
| Q3 24 | $6.3M | $69.8M | ||
| Q2 24 | $223.7M | $54.8M | ||
| Q1 24 | $272.6M | $66.9M |
自由现金流KOSPBH
| Q4 25 | — | $75.3M | ||
| Q3 25 | — | $55.4M | ||
| Q2 25 | — | $78.2M | ||
| Q1 25 | — | $58.4M | ||
| Q4 24 | — | $63.5M | ||
| Q3 24 | — | $67.8M | ||
| Q2 24 | — | $53.6M | ||
| Q1 24 | — | $63.8M |
自由现金流率KOSPBH
| Q4 25 | — | 26.6% | ||
| Q3 25 | — | 20.2% | ||
| Q2 25 | — | 31.3% | ||
| Q1 25 | — | 19.7% | ||
| Q4 24 | — | 21.9% | ||
| Q3 24 | — | 23.9% | ||
| Q2 24 | — | 20.1% | ||
| Q1 24 | — | 23.0% |
资本支出强度KOSPBH
| Q4 25 | — | 1.1% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 1.1% |
现金转化率KOSPBH
| Q4 25 | — | 1.68× | ||
| Q3 25 | — | 1.36× | ||
| Q2 25 | — | 1.66× | ||
| Q1 25 | — | 1.23× | ||
| Q4 24 | — | 1.07× | ||
| Q3 24 | 0.14× | 1.28× | ||
| Q2 24 | 3.74× | 1.12× | ||
| Q1 24 | 2.97× | 1.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KOS
| Ghana Segment | $134.6M | 46% |
| Gulf Of America | $80.7M | 27% |
| Mauritania And Senegal | $54.9M | 19% |
| Equatorial Guinea Segment | $24.3M | 8% |
PBH
| Womens Health | $51.8M | 18% |
| International OTC Healthcare | $47.7M | 17% |
| Gastrointestinal | $44.2M | 16% |
| Eye And Ear Care | $35.2M | 12% |
| Dermatologicals | $27.6M | 10% |
| Analgesics | $26.7M | 9% |
| Oral Care | $23.5M | 8% |
| Cough And Cold | $23.0M | 8% |
| Other Otc | $3.6M | 1% |
